NCT07856732 · State University of New York - Upstate Medical University
Using Silverlon® for Head and Neck Patients With Tracheostomies
What this study is about
The purpose of this study is to determine if prophylactic silver-nylon burn dressing Silverlon® prevents a severe skin reaction under tracheostomy collars. It also aims to establish whether patients can tolerate Silverlon® under their tracheostomy with daily removal and weekly changes.
View original scientific description
The purpose of this study is to determine if prophylactic silver-nylon burn dressing Silverlon® prevents a severe skin reaction under tracheostomy collars. It also aims to establish whether patients can tolerate Silverlon® under their tracheostomy with daily removal and weekly changes.
Interventions
DEVICE
Silverlon®
Silverlon® is a specialized, antimicrobial wound dressings that is approved in radiation dermatitis. The study is aimed at determining if this dressing is effective in prophylactically preventing dermatitis in high risk patients.
Primary outcome measures
Feasibility of Silveron dressing
Time frame: 7 weeks
The study will look at median use of the Silveron dressing. Success is defined as \> 50% over treatment days (\>17/35 days).
Who can participate
This study lists these criteria on ClinicalTrials.gov. A study coordinator reviews eligibility during screening — this page does not determine whether you qualify.
Inclusion criteria
- Undergoing definitive head and neck cancer (\>4 weeks of treatment)
- Have a tracheostomy
- Age ≥ 18 years
- Must be able to understand and write English
Exclusion criteria
- Inability to fulfill requirements of the protocol
- Presence of unhealed surgical wounds
- Subjects unable or unwilling to wear Silverlon dressings
- Active infection of treatment area
- Any co-morbidity or condition which, in the opinion of the investigator, may interfere with the assessments and procedures of this protocol.
- Subjects with known sensitivity to silver or nylon.
Where
- Syracuse, New York
Collaborators
Bravida Medical
Related conditions & keywords
Frequently asked questions
What is a clinical trial?
A clinical trial is a research study that tests new medical treatments, drugs, devices, or procedures to determine their safety and effectiveness. Trials are carefully designed and monitored to protect participants while advancing medical knowledge.
Is it safe to participate?
Clinical trials follow strict safety guidelines and ethical standards. Trials must be reviewed and approved, and participants are closely monitored by medical professionals throughout the study. You can withdraw at any time if you choose.
Will I be compensated?
Many clinical trials offer compensation for your time, travel expenses, and inconvenience. The specific compensation varies by study and will be discussed during the screening process. All study-related medical care is typically provided at no cost to participants.
Will I receive a placebo instead of treatment?
When effective treatment exists, participants typically receive either the standard treatment plus the study intervention, or the standard treatment plus placebo. You would not be denied effective care. Placebos are primarily used when no proven treatment is available, or in addition to standard care. Your trial consent form will clearly explain what treatments you may receive.
Can I leave a trial if I change my mind?
Absolutely. Participation in clinical trials is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty or loss of benefits to which you are otherwise entitled.
How long does a clinical trial last?
Trial duration varies widely depending on the study design and purpose. Some trials last just a few weeks, while others may continue for months or years. The study coordinator will provide specific timeline information during your screening call.
Data: ClinicalTrials.gov · synced Oct 5, 2026 · Source of record for eligibility and locations